Logo image of RILYM

B RILEY FINANCIAL INC - RILY 6 3/8 02/28/25 (RILYM) Stock Fundamental Analysis

NASDAQ:RILYM - Nasdaq - US05580M8689 - Currency: USD

25.11  -0.01 (-0.04%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RILYM. RILYM was compared to 236 industry peers in the Capital Markets industry. Both the profitability and financial health of RILYM have multiple concerns. RILYM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RILYM had negative earnings in the past year.
RILYM had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RILYM reported negative net income in multiple years.
RILYM had a positive operating cash flow in 4 of the past 5 years.
RILYM Yearly Net Income VS EBIT VS OCF VS FCFRILYM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

1.2 Ratios

The Return On Assets of RILYM (-40.09%) is worse than 94.67% of its industry peers.
Industry RankSector Rank
ROA -40.09%
ROE N/A
ROIC N/A
ROA(3y)0.98%
ROA(5y)2.8%
ROE(3y)-2.83%
ROE(5y)10.63%
ROIC(3y)N/A
ROIC(5y)N/A
RILYM Yearly ROA, ROE, ROICRILYM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

1.3 Margins

In the last couple of years the Operating Margin of RILYM has declined.
RILYM's Gross Margin of 45.64% is in line compared to the rest of the industry. RILYM outperforms 44.00% of its industry peers.
In the last couple of years the Gross Margin of RILYM has declined.
The Profit Margin and Operating Margin are not available for RILYM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.64%
OM growth 3Y-31.23%
OM growth 5Y-5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-5.38%
RILYM Yearly Profit, Operating, Gross MarginsRILYM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

RILYM has more shares outstanding than it did 1 year ago.
RILYM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RILYM is higher compared to a year ago.
RILYM Yearly Shares OutstandingRILYM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
RILYM Yearly Total Debt VS Total AssetsRILYM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -0.88, we must say that RILYM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of RILYM (-0.88) is worse than 84.89% of its industry peers.
The Debt to FCF ratio of RILYM is 6.58, which is on the high side as it means it would take RILYM, 6.58 years of fcf income to pay off all of its debts.
RILYM has a Debt to FCF ratio (6.58) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.58
Altman-Z -0.88
ROIC/WACCN/A
WACCN/A
RILYM Yearly LT Debt VS Equity VS FCFRILYM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

RILYM has a Current Ratio of 1.09. This is a normal value and indicates that RILYM is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.09, RILYM perfoms like the industry average, outperforming 46.22% of the companies in the same industry.
A Quick Ratio of 0.89 indicates that RILYM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.89, RILYM is doing worse than 60.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.89
RILYM Yearly Current Assets VS Current LiabilitesRILYM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for RILYM have decreased strongly by -1016.75% in the last year.
RILYM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.31%.
RILYM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.48% yearly.
EPS 1Y (TTM)-1016.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-271.15%
Revenue 1Y (TTM)-50.31%
Revenue growth 3Y18.88%
Revenue growth 5Y28.48%
Sales Q2Q%-61.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RILYM Yearly Revenue VS EstimatesRILYM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RILYM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RILYM Price Earnings VS Forward Price EarningsRILYM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

RILYM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RILYM is cheaper than 89.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.37
EV/EBITDA N/A
RILYM Per share dataRILYM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 38.10%, RILYM is a good candidate for dividend investing.
RILYM's Dividend Yield is rather good when compared to the industry average which is at 8.23. RILYM pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, RILYM pays a better dividend.
Industry RankSector Rank
Dividend Yield 38.1%

5.2 History

The dividend of RILYM is nicely growing with an annual growth rate of 43.04%!
RILYM has been paying a dividend for over 5 years, so it has already some track record.
RILYM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)43.04%
Div Incr Years0
Div Non Decr Years3
RILYM Yearly Dividends per shareRILYM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

RILYM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-8.31%
EPS Next 2YN/A
EPS Next 3YN/A
RILYM Yearly Income VS Free CF VS DividendRILYM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

More info and screens

B RILEY FINANCIAL INC - RILY 6 3/8 02/28/25

NASDAQ:RILYM (2/27/2025, 8:08:07 PM)

25.11

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-03 2025-03-03/amc
Earnings (Next)05-13 2025-05-13
Inst Owners25.73%
Inst Owner ChangeN/A
Ins Owners35.22%
Ins Owner ChangeN/A
Market Cap765.86M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 38.1%
Yearly Dividend5.1
Dividend Growth(5Y)43.04%
DP-8.31%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-15 2025-01-15 (0.3984375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.02
P/FCF 2.37
P/OCF 2.31
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-28.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)10.59
FCFY42.19%
OCF(TTM)10.88
OCFY43.32%
SpS24.54
BVpS-16.31
TBVpS-38.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.09%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.64%
FCFM 43.16%
ROA(3y)0.98%
ROA(5y)2.8%
ROE(3y)-2.83%
ROE(5y)10.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-31.23%
OM growth 5Y-5.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.85%
GM growth 5Y-5.38%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.58
Debt/EBITDA N/A
Cap/Depr 18.97%
Cap/Sales 1.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.89
Altman-Z -0.88
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)9.33%
Cap/Depr(5y)11.35%
Cap/Sales(3y)0.34%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1016.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-271.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.31%
Revenue growth 3Y18.88%
Revenue growth 5Y28.48%
Sales Q2Q%-61.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-339.07%
EBIT growth 3Y-18.25%
EBIT growth 5Y22.01%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y125.61%
FCF growth 3Y-32.92%
FCF growth 5YN/A
OCF growth 1Y129.22%
OCF growth 3Y-24.83%
OCF growth 5YN/A